SHANGHAI, China, Nov. 25, 2025 (GLOBE NEWSWIRE) — Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Operational and Financial Highlights:Loan facilitation volume1 was RMB32.2 billion (US$4.5 billion), representing an increase of 20.6% from the same period of 2024.Average borrowing amount per borrowing was RMB9,115 (US$1,280), representing an increase of 19.5% from the same period of 2024.Repeat borrowing contribution2 was 78.6% compared with 73.0% in the same period of 2024.90 day+ delinquency ratio3 was 1.33% as of September 30, 2025.Net revenue was RMB1,470.2 million (US$206.5 million), representing an increase of 1.8% from the same period of 2024.Income...

Quarterly Total Revenues Reached RMB21,793.9 million (US$3,061.4 million)i Quarterly Vehicle Deliveries were 87,071 units SHANGHAI, Nov. 25, 2025 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced its unaudited financial results for the third quarter ended September 30, 2025. Operating Highlights for the Third Quarter of 2025Vehicle deliveries were 87,071 in the third quarter of 2025, representing an increase of 40.8% from the third quarter of 2024, and an increase of 20.8% from the second quarter of 2025. The deliveries consisted of 36,928 vehicles from the Company’s premium smart electric vehicle brand NIO, 37,656 vehicles from the Company’s family-oriented smart electric vehicle brand ONVO, and...

Successful dual primary listing in Hong Kong — Raised more than US$800 million1 to accelerate mass production, large-scale commercialization, R&D innovation and new market expansion. Official launch of Gen-7 Robotaxi operations — Kicked off fully driverless commercial operations in Guangzhou, Shenzhen, and Beijing. Continued progress in Robotaxi commercialization — Robotaxi revenues up by 89.5% year-over-year, with fare-charging revenues surging by over 200%.NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) — Pony AI Inc. (“Pony.ai” or the “Company”) (NASDAQ: PONY; HKEX: 2026), a global leader in achieving large-scale commercialization of autonomous mobility, today announced its unaudited financial results for the third quarter ended September 30, 2025. Dr. James Peng, Chairman and Chief Executive Officer of Pony.ai, commented,...

BEIJING, China, Nov. 25, 2025 (GLOBE NEWSWIRE) — Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced its unaudited financial results for the quarter ended September 30, 2025. Third Quarter 2025 HighlightsTotal revenues were RMB658.9 million (US$92.6 million), compared with RMB845.0 million in the same period of 2024. Gross margin was 61.3%, compared with 63.9% in the same period of 2024. Net loss was RMB46.7 million (US$6.6 million), compared with RMB9.0 million in the same period of 2024. Adjusted net loss (non-GAAP)[1] was RMB21.0 million (US$3.0 million), compared with RMB13.1 million in the same period of 2024. Average monthly subscribing members[2] were 14.3 million in the third quarter of 2025.“We are firmly on track to achieve full-year non-GAAP breakeven,...

COMPANY ANNOUNCEMENT No. 246/2025         Tvis, 25 November 2025 Interim report Q3 2025 (July 1 – September 30) (All figures in brackets refer to the corresponding period in 2024) Delivering stable sales growth and gross margin improvements despite a volatile market. CEO Torben Paulin:“Sales in the third quarter developed in line with our expectations, with growth recorded in both the B2B and B2C segments. Total sales for the quarter increased by 4% year-on-year to DKK 289 million, corresponding to organic growth of 3%. Order intake improved during the quarter, with high single-digit growth in the core business overall and double-digit growth in the B2C segment. In the B2B segment, project orders declined slightly compared to the prior year, while orders from builders of turnkey residential houses showed a strong positive trend. The...

                                                 Press release Lesquin, November 24, 2025,18:00 HALF-YEAR RESULTS 2025-2026:EBITDA AT €36.5 M, UP BY 17.5% OPERATING PROFIT OF €4.7 M, UP BY 24.7%CONFIRMATION OF THE GROUP’S ANNUAL TARGETS BIGBEN INTERACTIVE (ISIN FR 0000074072) today announces its consolidated half-year results (period from April 1, 2025 to September 30, 2025) for the 2025-2026 financial year, reviewed by the board of directors on November 24, 2025. The limited review procedures by the statutory auditors are ongoing; the limited review report of the statutory auditors will be issued upon publication of the half-year financial report.Consolidated IFRS figures (€ million) First half 2025-2026 First half 2024-2025 ChangeSales (IFRS) 135.4          135.9 -0.3%Gross margin% of sales 73.554.3%          69.5          ...

                                                Press Release Lesquin, November 24, 2025 – 6:00 PM HALF-YEAR RESULTS 2025-2026:EBITDA AT €33.6 M, UP 18.7% OPERATING PROFIT OF €4.2 M, UP 30.4%BUSINESS GROWTH AND OPERATING PROFIT EXPECTED FOR THE FULL FINANCIAL YEAR NACON (ISIN FR 0013482791) today announces its consolidated half-year results (period from April 1, 2025 to September 30, 2025) for the 2025-2026 financial year, reviewed by the board of directors on November 24, 2025. The limited review procedures by the statutory auditors are ongoing; the limited review report of the statutory auditors will be issued upon publication of the half-year financial report.Consolidated in M€ IFRS First Half2025-2026 First Half2024-2025 ChangeSales (IFRS) 78.1 77.0 +1.4%Gross Margin% of sales 54.469.7%          50.7 65.8% +7.4%EBITDA%...

Record Fiscal Year Results, with Net Income of $305.9 million, up 17% Quarterly Net Operating Revenues of $585.1 million, up 29%   Record Quarterly Net Income of $85.7 million, Quarterly ROE of 15.2% Quarterly Diluted EPS of $1.57 per share, Fiscal Year of $5.89 per share NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — StoneX Group Inc. (the “Company”; NASDAQ: SNEX), a leading financial services franchise connecting clients to global markets, today announced its financial results for the fiscal fourth quarter and year ended September 30, 2025. Sean O’Connor, the Company’s Executive Vice-Chairman of the Board, stated, “We are pleased to announce our results to close out fiscal year 2025, one which marked another record annual performance in both revenues and net income and one in which we continue to grow both our product capabilities...

Fiscal 2026 Guidance Reflects Robust Growth FORT COLLINS, Colo., Nov. 24, 2025 (GLOBE NEWSWIRE) — Woodward, Inc. (NASDAQ:WWD) today reported financial results for its fiscal year 2025 and fourth quarter ending September 30, 2025. All amounts are presented on an as reported (U.S. GAAP) basis unless otherwise indicated. All per share amounts are presented on a fully diluted basis. All comparisons are made to the same period of the prior year unless otherwise stated. All references to years are references to the Company’s fiscal year unless otherwise stated. Fourth Quarter and Fiscal Year 2025 Overview  Fourth Quarter 2025   Fiscal Year 2025Net sales $995M, +16%   $3.6B, +7%Net earnings $138M, +66%   $442M, +19%Adjusted net earnings1 $129M, +49%   $424M, +12%Earnings per share (EPS) $2.23, +64%   $7.19, +20%Adjusted...

Financial foundation toward self-sustained long-term growth established with the closing with HealthCare Royalty (“HCRx”) of a non-dilutive royalty financing valued up to $71 million Progress in the JNJ-1900 (NBTXR3) global development program announced including first data from a Phase 1 esophageal cancer study sponsored by The University of Texas MD Anderson Cancer Center (“MD Anderson”) Completed the NANORAY-312 sponsorship transfer to Johnson & Johnson in the majority of regions Advanced the Curadigm Nanoprimer program with updated plans for internal pipeline development and external collaborations Clinical updates from ongoing or completed JNJ-1900 (NBTXR3) Phase 1 studies sponsored by Nanobiotix or MD Anderson in melanoma, lung cancer amenable to re-irradiation, pancreatic cancer, and esophageal cancer expected in 2026 €20.4...